368
Views
23
CrossRef citations to date
0
Altmetric
Reviews

New therapies for pulmonary arterial hypertension: an update on current bench to bedside translation

, &
Pages 469-488 | Published online: 31 Mar 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ronald Zolty. (2023) Advances in the discovery of drugs that treat pulmonary arterial hypertension. Expert Opinion on Drug Discovery 18:4, pages 445-466.
Read now
Simon Malenfant, Guillaume Margaillan, Jérémy Edwin Loehr, Sébastien Bonnet & Steeve Provencher. (2013) The emergence of new therapeutic targets in pulmonary arterial hypertension: from now to the near future. Expert Review of Respiratory Medicine 7:1, pages 43-55.
Read now

Articles from other publishers (21)

Qiwei Wilton Sun & Zhongjie Sun. (2022) Stem cell therapy for pulmonary arterial hypertension: An update. The Journal of Heart and Lung Transplantation 41:6, pages 692-703.
Crossref
Chetan Sharma, Joseph Burns, Aparna Kulkarni, Jane E. Cerise, Fernando Molina Berganza & Denise A. Hayes. (2021) Continuous and intermittent administration of intravenous sildenafil in critically ill infants with pulmonary hypertension. Pediatric Pulmonology 56:9, pages 2973-2978.
Crossref
Jingyuan Zhang, Xiaohui Lu, Mei Liu, Hanlu Fan, Han Zheng, Shanshan Zhang, Nafis Rahman, Sławomir Wołczyński, Adam Kretowski & Xiangdong Li. (2020) Melatonin inhibits inflammasome-associated activation of endothelium and macrophages attenuating pulmonary arterial hypertension. Cardiovascular Research 116:13, pages 2156-2169.
Crossref
Ronald Zolty. (2020) Pulmonary arterial hypertension specific therapy: The old and the new. Pharmacology & Therapeutics 214, pages 107576.
Crossref
Liang Li, Wenpeng Zhang, Feng Lin, Xinqiang Lu, Wei Chen, Xingzhou Li, Xinbo Zhou, Ruibin Su, Lili Wang, Zhibing Zheng & Song Li. (2019) Synthesis and biological evaluation of pyrazolo[3,4-b]pyridine-3-yl pyrimidine derivatives as sGC stimulators for the treatment of pulmonary hypertension. European Journal of Medicinal Chemistry 173, pages 107-116.
Crossref
Wei Li, Aili Guo, Lijuan Wang, Qingyu Kong, Rong Wang, Li Han & Cuifen Zhao. (2016) Expression of peptide fragments from proADM and involvement of mitogen-activated protein kinase signaling pathways in pulmonary remodeling induced by high pulmonary blood flow. Congenital Anomalies 56:1, pages 28-34.
Crossref
Mala Sharma, Sowmya Pinnamaneni, Wilbert S. Aronow, Bartosz Jozwik & William H. Frishman. (2014) Existing Drugs and Agents Under Investigation for Pulmonary Arterial Hypertension. Cardiology in Review 22:6, pages 297-305.
Crossref
Jinyan FuYiu-Fai ChenXiangmin ZhaoJudy R. CreightonYuanyuan GuoFadi G. HageSuzanne OparilDaisy D. Xing. (2014) Targeted Delivery of Pulmonary Arterial Endothelial Cells Overexpressing Interleukin-8 Receptors Attenuates Monocrotaline-Induced Pulmonary Vascular Remodeling. Arteriosclerosis, Thrombosis, and Vascular Biology 34:7, pages 1539-1547.
Crossref
Sara B. Seidelmann, Janet K. Lighthouse & Daniel M. Greif. (2013) Development and pathologies of the arterial wall. Cellular and Molecular Life Sciences 71:11, pages 1977-1999.
Crossref
Nikki L. Jernigan & Thomas C. Resta. (2014) Calcium Homeostasis and Sensitization in Pulmonary Arterial Smooth Muscle. Microcirculation 21:3, pages 259-271.
Crossref
W. Li, Q.Y. Kong, C.F. Zhao, F. Zhao, F.H. Li, W. Xia, R. Wang, Y.M. Hu & M. Hua. (2013) Adrenomedullin and adrenotensin regulate collagen synthesis and proliferation in pulmonary arterial smooth muscle cells. Brazilian Journal of Medical and Biological Research 46:12, pages 1047-1055.
Crossref
Baktybek Kojonazarov, Himal Luitel, Akylbek Sydykov, Bhola K. Dahal, Mark J. Paul‐Clark, Sara Bonvini, Anna Reed, Ralph T. Schermuly & Jane A. Mitchell. (2013) The Peroxisome Proliferator–Activated Receptor β/δ Agonist GW0742 has Direct Protective Effects on Right Heart Hypertrophy. Pulmonary Circulation 3:4, pages 926-935.
Crossref
Caroline O’Connell, Dermot S. O’Callaghan & Marc Humbert. (2013) Novel Medical Therapies for Pulmonary Arterial Hypertension. Clinics in Chest Medicine 34:4, pages 867-880.
Crossref
Hans‐Jürgen Seyfarth, Stefan Hammerschmidt, Michael Halank, Petra Neuhaus & Hubert R. Wirtz. (2013) Everolimus in Patients with Severe Pulmonary Hypertension: A Safety and Efficacy Pilot Trial. Pulmonary Circulation 3:3, pages 632-638.
Crossref
. (2011) Current World Literature. Current Opinion in Cardiology 26:4, pages 356-361.
Crossref
Niki Katsiki, Anthony S Wierzbicki & Dimitri P Mikhailidis. (2011) Pulmonary arterial hypertension and statins: an update. Current Opinion in Cardiology 26:4, pages 322-326.
Crossref
Kenji Kuwasako, Kazuo Kitamura, Sayaka Nagata, Tomomi Hikosaka, Yoshio Takei & Johji Kato. (2011) Shared and separate functions of the RAMP-based adrenomedullin receptors. Peptides 32:7, pages 1540-1550.
Crossref
Jean-Luc Vachiéry. (2011) Prostacyclins in pulmonary arterial hypertension: the need for earlier therapy. Advances in Therapy 28:4, pages 251-269.
Crossref
Se-Na Lee, Myung-Gyou Kim, Myoung-Hee Kim, Hyung-Jun Kim, Hak-Jun Jo & Kang-Hyun Leem. (2011) Effects of Yukmigeehwang-hwan Extracts on the Elastase Activity and DPPH and NO Scavenging Activities Original Articles. Journal of Pharmacopuncture 14:1, pages 61-69.
Crossref
Sarah M. WeakleyJun JiangJianming LuXinwen WangPeter H. LinQizhi YaoChangyi Chen. (2011) Natural antioxidant dihydroxybenzyl alcohol blocks ritonavir-induced endothelial dysfunction in porcine pulmonary arteries and human endothelial cells. Medical Science Monitor 17:9, pages BR235-BR241.
Crossref
Jing Tian, Sohrab Fratz, Yali Hou, Qing Lu, Agnes Görlach, John Hess, Christian Schreiber, Sanjeev A. Datar, Peter Oishi, John NechtmanRobert PodolskyJin-Xiong SheJeffrey R. Fineman & Stephen M. Black. (2011) Delineating the angiogenic gene expression profile before pulmonary vascular remodeling in a lamb model of congenital heart disease. Physiological Genomics 43:2, pages 87-98.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.